CAM
GILD icon

CMT Asset Management’s Gilead Sciences GILD Stock Holding History

CMT Asset Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-143,100
Closed -$11.6M – 54
2017
Q3 		$11.6M Buy
143,100
+86,400
+152% +$6.61M 0.56% 63
2017
Q2 		$4.01M Buy
56,700
+17,900
+46% +$1.19M 0.27% 88
2017
Q1 		$2.63M Sell
38,800
-80,200
-67% -$5.64M 0.22% 90
2016
Q4 		$8.52M Sell
119,000
-78,400
-40% -$5.83M 0.4% 67
2016
Q3 		$15.6M Buy
197,400
+11,300
+6% +$918K 0.72% 50
2016
Q2 		$15.5M Buy
186,100
+55,600
+43% +$4.93M 0.78% 44
2016
Q1 		$12M Sell
130,500
-17,600
-12% -$1.59M 0.8% 43
2015
Q4 		$15M Sell
148,100
-48,800
-25% -$5.08M 0.77% 38
2015
Q3 		$19.3M Buy
196,900
+1,300
+0.7% +$144K 1.08% 31
2015
Q2 		$22.9M Sell
195,600
-32,800
-14% -$3.58M 1.41% 18
2015
Q1 		$22.4M Buy
228,400
+76,600
+50% +$7.78M 1.63% 16
2014
Q4 		$14.3M Buy
151,800
+82,800
+120% +$8.56M 0.85% 36
2014
Q3 		$7.34M Buy
+69,000
New +$6.76M 0.38% 70

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

CMT Asset Management's GILD Position: Q4 2017 in Review

CMT Asset Management sold out of Gilead Sciences (GILD) in Q4 2017, closing a stake of 6,322 shares — an estimated $512K sold.

CMT Asset Management first reported a position in GILD in Q3 2014 and held it in 9 quarters. The position peaked at $8.23M in Q1 2015. 1,575 funds tracked by Wall St. Rank hold GILD as of Q4 2017.

  • CMT Asset Management reported no remaining Gilead Sciences position as of Q4 2017 after selling out during the quarter.
  • CMT Asset Management sold 6,322 Gilead Sciences shares in Q4 2017, an estimated $512K.
  • CMT Asset Management first reported a position in Gilead Sciences in Q3 2014 and held it in 9 quarters.
  • CMT Asset Management's Gilead Sciences position peaked at $8.23M in Q1 2015.
  • 1,575 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2017.

Based on CMT Asset Management's 13F filing for Q4 2017, filed 14 Feb 2018.